Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
AI HVAC optimization platform reducing industrial energy costs 15-30% in Southeast Asian factories; YC W22 backed competing with Siemens and Honeywell for smart building energy management.
Axross is a Singapore-based energy management company providing AI-driven HVAC (Heating, Ventilation, and Air Conditioning) control systems for industrial manufacturers and commercial buildings across Southeast Asia — using IoT sensors, data analytics, and machine learning to optimize cooling and ventilation energy consumption, reducing energy costs 15-30% in factories and facilities where HVAC represents 40-60% of total electricity spend. Founded in 2021 and a Y Combinator W22 graduate, Axross achieved $1 million in revenue in 2024 with a 7-person team.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.